The table below shows ARROWHEAD PHARMACEUTICALS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q2 2025
Q1 2025
Q4 2024
Q2 2024
Revenue
$73.74M
$264.03M
$27.77M
$542.71M
$2.50M
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$173.25M
$177.20M
-
$133.10M
$137.00M
-
ARWR annual revenue (10-K history)
ARROWHEAD PHARMACEUTICALS, INC. reported annual revenue of $829.45M for fiscal year 2025. That is up 23258.2% from $3.55M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $158.33K (FY 2016) to $829.45M. Figures come from the company's audited annual reports as filed with the SEC.
